INVO Bioscience Inc
NASDAQ:INVO
INVO Bioscience Inc
PP&E Gross
INVO Bioscience Inc
PP&E Gross Peer Comparison
Competitive PP&E Gross Analysis
Latest Figures & CAGR of Competitors
Company | PP&E Gross | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
INVO Bioscience Inc
NASDAQ:INVO
|
PP&E Gross
$3.8m
|
CAGR 3-Years
166%
|
CAGR 5-Years
116%
|
CAGR 10-Years
N/A
|
|
Boston Scientific Corp
NYSE:BSX
|
PP&E Gross
$3.3B
|
CAGR 3-Years
11%
|
CAGR 5-Years
13%
|
CAGR 10-Years
8%
|
|
Stryker Corp
NYSE:SYK
|
PP&E Gross
$3.8B
|
CAGR 3-Years
6%
|
CAGR 5-Years
7%
|
CAGR 10-Years
13%
|
|
Abbott Laboratories
NYSE:ABT
|
PP&E Gross
$10.1B
|
CAGR 3-Years
5%
|
CAGR 5-Years
4%
|
CAGR 10-Years
5%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
PP&E Gross
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Shockwave Medical Inc
NASDAQ:SWAV
|
PP&E Gross
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is INVO Bioscience Inc's PP&E Gross?
PP&E Gross
3.8m
USD
Based on the financial report for Mar 31, 2024, INVO Bioscience Inc's PP&E Gross amounts to 3.8m USD.
What is INVO Bioscience Inc's PP&E Gross growth rate?
PP&E Gross CAGR 5Y
116%
Over the last year, the PP&E Gross growth was 74%. The average annual PP&E Gross growth rates for INVO Bioscience Inc have been 166% over the past three years , 116% over the past five years .